Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.
Solomón MT, Selva JC, Figueredo J, Vaquer J, Toledo C, Quintanal N, Salva S, Domíngez R, Alert J, Marinello JJ, Catalá M, Griego MG, Martell JA, Luaces PL, Ballesteros J, de-Castro N, Bach F, Crombet T. Solomón MT, et al. Among authors: alert j. BMC Cancer. 2013 Jun 19;13:299. doi: 10.1186/1471-2407-13-299. BMC Cancer. 2013. PMID: 23782513 Free PMC article. Clinical Trial.
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck.
Rodríguez MO, Rivero TC, del Castillo Bahi R, Muchuli CR, Bilbao MA, Vinageras EN, Alert J, Galainena JJ, Rodríguez E, Gracias E, Mulén B, Wilkinson B, de Armas EL, Pérez K, Pineda I, Frómeta M, Leonard I, Mullens V, Viada C, Luaces P, Torres O, Iznaga N, Crombet T. Rodríguez MO, et al. Among authors: alert j. Cancer Biol Ther. 2010 Mar 1;9(5):343-9. doi: 10.4161/cbt.9.5.10981. Epub 2010 Mar 20. Cancer Biol Ther. 2010. PMID: 20448462 Clinical Trial.
Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.
Ramos-Suzarte M, Lorenzo-Luaces P, Lazo NG, Perez ML, Soriano JL, Gonzalez CE, Hernadez IM, Albuerne YÁ, Moreno BP, Alvarez ES, Callejo IP, Alert J, Martell JA, Gonzalez YS, Gonzalez YS, Astudillo de la Vega H, Ruiz-Garcia EB, Ramos TC. Ramos-Suzarte M, et al. Among authors: alert j. Cancer Biol Ther. 2012 Jun;13(8):600-5. doi: 10.4161/cbt.19849. Epub 2012 Jun 1. Cancer Biol Ther. 2012. PMID: 22555809 Clinical Trial.
Prolonged use of nimotuzumab in children with central nervous system tumors: safety and feasibility.
Cabanas R, Saurez G, Alert J, Reyes A, Valdes J, Gonzalez MC, Pedrayes JL, Valle L, Infante M, Avila M, Herrera R, Hechavarria E, Rios M, Fernández A, Lorenzo Luaces P, Crombet Ramos T. Cabanas R, et al. Among authors: alert j. Cancer Biother Radiopharm. 2014 May;29(4):173-8. doi: 10.1089/cbr.2013.1591. Epub 2014 Apr 30. Cancer Biother Radiopharm. 2014. PMID: 24784755
Incidence of childhood cancer in Cuba (1986-1990).
Martín AA, Alert JA, Renó JS, Lonchong M, Grueiro S. Martín AA, et al. Among authors: alert ja. Int J Cancer. 1997 Aug 7;72(4):551-5. doi: 10.1002/(sici)1097-0215(19970807)72:4<551::aid-ijc1>3.0.co;2-p. Int J Cancer. 1997. PMID: 9259390 Free article.
Chromosomal anomalies in children treated for cancer.
García J, Ruisánchez N, Longchong M, Valdés M, Puig M, Menéndez J, Alert J, Ramos S. García J, et al. Among authors: alert j. Neoplasma. 1986;33(5):657-62. Neoplasma. 1986. PMID: 3785470
20 results